These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32439936)

  • 1. Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer.
    Suraweera A; Duff A; Adams MN; Jekimovs C; Duijf PHG; Liu C; McTaggart M; Beard S; O'Byrne KJ; Richard DJ
    Br J Cancer; 2020 Aug; 123(4):591-603. PubMed ID: 32439936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the COMMD4-H2B protein complex in lung cancer.
    Tang M; Burgess JT; Fisher M; Boucher D; Bolderson E; Gandhi NS; O'Byrne KJ; Richard DJ; Suraweera A
    Br J Cancer; 2023 Dec; 129(12):2014-2024. PubMed ID: 37914802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-Regulation of HBXIP Inhibits Non-Small Cell Lung Cancer Growth and Enhances the Anti-Tumor Immunity of Mice by Reducing NRP-1.
    Wang L; Sun M; Lin X; Lei Y; Yin Z; Zhou W
    Ann Clin Lab Sci; 2021 Jul; 51(4):487-493. PubMed ID: 34452886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Krüppel-Like Factor 6 Downregulation Is Connected with a Poor Prognosis and Tumor Growth in Non-Small-Cell Lung Cancer.
    Zeng B; Lin J; Cai X; Che L; Zeng W; Liu S
    Comput Math Methods Med; 2022; 2022():3193553. PubMed ID: 35136416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RBBP4: A novel diagnostic and prognostic biomarker for non-small-cell lung cancer correlated with autophagic cell death.
    Zhan Y; Zhang Z; Yin A; Su X; Tang N; Chen Y; Zhang Z; Chen W; Wang J; Wang W
    Cancer Med; 2024 Aug; 13(15):e70090. PubMed ID: 39109577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits.
    Wu Z; Liu Z; Jiang X; Mi Z; Meng M; Wang H; Zhao J; Zheng B; Yuan Z
    J Exp Clin Cancer Res; 2019 Aug; 38(1):341. PubMed ID: 31387622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of Mig-6 is associated with poor survival outcome in NSCLC and inhibits cell apoptosis via ERK-mediated upregulation of Bcl-2.
    Li Z; Qu L; Zhong H; Xu K; Qiu X; Wang E
    Oncol Rep; 2014 Apr; 31(4):1707-14. PubMed ID: 24573418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development.
    Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C
    BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
    Li X; Zheng H
    Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of CASS4 promotes invasion in non-small cell lung cancer by activating the AKT signaling pathway and inhibiting E-cadherin expression.
    Li A; Zhang W; Xia H; Miao Y; Zhou H; Zhang X; Dong Q; Li Q; Qiu X; Wang E
    Tumour Biol; 2016 Nov; 37(11):15157-15164. PubMed ID: 27677288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
    Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
    Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
    BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
    Han Y; Tian H; Chen P; Lin Q
    Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA CARLo-5 is a negative prognostic factor and exhibits tumor pro-oncogenic activity in non-small cell lung cancer.
    Luo J; Tang L; Zhang J; Ni J; Zhang HP; Zhang L; Xu JF; Zheng D
    Tumour Biol; 2014 Nov; 35(11):11541-9. PubMed ID: 25129441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical and prognostic significance of YWHAZ in non-small-cell lung cancer patients: Immunohistochemical analysis.
    Deng Y; Zheng J; Ma J
    J Cell Biochem; 2019 Apr; 120(4):6290-6298. PubMed ID: 30378158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non-Small Cell Lung Cancer.
    Adams MN; Burgess JT; He Y; Gately K; Snell C; Zhang SD; Hooper JD; Richard DJ; O'Byrne KJ
    J Thorac Oncol; 2017 Jul; 12(7):1071-1084. PubMed ID: 28487093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1.
    Xiao L; Zhou H; Li XP; Chen J; Fang C; Mao CX; Cui JJ; Zhang W; Zhou HH; Yin JY; Liu ZQ
    Oncotarget; 2016 Jun; 7(26):40038-40046. PubMed ID: 27223073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression.
    Lu KH; Li W; Liu XH; Sun M; Zhang ML; Wu WQ; Xie WP; Hou YY
    BMC Cancer; 2013 Oct; 13():461. PubMed ID: 24098911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.